Related Experiment Video
Updated: Mar 11, 2026

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions
Published on: October 30, 2016
Immunological and Translational Aspects of NK Cell-Based Antitumor Immunotherapies
Maxim Shevtsov1, Gabriele Multhoff2
1Radiation Oncology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany; Institute of Cytology of the Russian Academy of Sciences (RAS), St. Petersburg, Russia.
Abstract:
Natural killer (NK) cells play a pivotal role in the first line of defense against cancer. NK cells that are deficient in CD3 and a clonal T cell receptor (TCR) can be subdivided into two major subtypes, CD56dimCD16+ cytotoxic and CD56brightCD16- immunoregulatory NK cells. Cytotoxic NK cells not only directly kill tumor cells without previous stimulation by cytotoxic effector molecules, such as perforin and granzymes or via death receptor interactions, but also act as regulatory cells for the immune system by secreting cytokines and chemokines. The aim of this review is to highlight therapeutic strategies utilizing autologous and allogenic NK cells, combinations of NK cells with monoclonal antibodies to induce antibody-dependent cellular cytotoxicity, or immune checkpoint inhibitors. Additionally, we discuss the use of chimeric antigen receptor-engineered NK cells in cancer immunotherapy.
Insights
Natural killer (NK) cells are crucial for cancer defense. This review explores NK cell-based immunotherapies, including engineered NK cells and combinations with antibodies or inhibitors, for enhanced cancer treatment.
Area of Science:
- Immunology
- Oncology
- Biotechnology
Background:
- Natural killer (NK) cells are key innate immune cells in the initial defense against malignancies.
- NK cells are classified into CD56dimCD16+ cytotoxic and CD56brightCD16- immunoregulatory subtypes.
- Cytotoxic NK cells eliminate tumor cells directly and regulate immunity via cytokine secretion.
Approach:
- This review highlights therapeutic strategies involving NK cells for cancer immunotherapy.
- It examines the use of autologous and allogenic NK cells.
- Combinations with monoclonal antibodies and immune checkpoint inhibitors are discussed, alongside chimeric antigen receptor-engineered NK cells.
Key Points:
- NK cells offer direct tumor cell killing and immune regulation.
- Therapeutic strategies include adoptive transfer of NK cells.
- Combining NK cells with monoclonal antibodies or immune checkpoint inhibitors enhances anti-cancer effects.
- Chimeric antigen receptor (CAR)-engineered NK cells represent a novel approach.
Conclusions:
- NK cell-based immunotherapies show significant promise in cancer treatment.
- Engineered NK cells and combination therapies offer new avenues for overcoming cancer.
- Further research into NK cell functions and therapeutic applications is warranted.
More Related Videos
Related Concept Videos
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Tumor Immunotherapy
Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Immune Surveillance by NK Cells and Phagocytes
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...

